Josh Hawley seeks DOJ abortion drug investigation amid FDA safety review

Josh Hawley seeks DOJ abortion drug investigation amid FDA safety review


President Donald Trump’s Justice Department is facing mounting pressure from Republican and conservative advocates to investigate Danco Laboratories, the primary distributor of the abortion drug mifepristone, as scrutiny intensifies over the drug’s safety and regulatory oversight.

Sen. Josh Hawley (R-MO) is leading that effort, penning a letter Tuesday to acting Attorney General Todd Blanche asking him to open a sweeping investigation into the company’s business practices, approval process, and compliance with federal law.

The DOJ confirmed to the Washington Examiner that it has received Hawley’s letter but did not say whether it would open a formal investigation.

“President Trump’s record on protecting unborn life and defending women’s health is unmatched,” a department spokesperson said in a statement. “The Department of Justice will continue to advance those priorities by asking courts to allow the FDA to complete its review of mifepristone safety data and by investigating any person or entity that engaged in

Continue reading

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!